Related Experiment Video
Updated: May 23, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab
Stejara A Netea1,2, Diana van Stijn1, Mariken P Gruppen1
1Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
An infant presented with macrophage activation syndrome as part of Kawasaki disease, and was first treated with canakinumab, followed by methylprednisolone and IVIG. Despite early treatment, giant coronary artery aneurysms developed transiently, questioning the singular role of IL-1 in KD.
An infant presented with macrophage activation syndrome as part of Kawasaki disease, and was first treated with canakinumab, followed by methylprednisolone and IVIG. Despite early treatment, giant coronary artery aneurysms developed transiently, questioning the singular role of IL-1 in KD.